• Publications
  • Influence
Neuroendocrine Differentiation in Prostate Cancer: From Lab to Bedside
Objectives: To discuss the current knowledge on induction, production, sustenance and promotion of neuroendocrine differentiation in human prostate cancer. Methods: Review of the literature usingExpand
  • 48
  • 3
CXCL12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and CXCR4 positive circulating tumoral cells in lung draining venous blood.
OBJECTIVES Lung cancer is the main cause of cancer-related death in Western countries. Despite early diagnosis, approximately 40% of patients have undergone surgical resection for localized non-smallExpand
  • 36
  • 1
NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension?
OBJECTIVES Neuroendocrine differentiation is a common feature of prostate cancer (pCA). NeuroD1 is a neuronal transcription factor able to convert epithelial cells into neurons. The aim of the studyExpand
  • 17
Parallel determination of NeuroD1, chromogranin-A, KI67 and androgen receptor expression in surgically treated prostate cancers.
PURPOSE Neuroendocrine differentiation is a hallmark of prostate cancer. The aim of our study was the detection of the parallel expression of neuroendocrine related markers using a prostate tissueExpand
  • 10
  • PDF
CD90 expression in atypical meningiomas and meningioma metastasis.
OBJECTIVES Meningiomas are slow-growing intracranial/intraspinal tumors, with a wide range of histopathologic variants. The more aggressive atypical and malignant types can disseminate via the venousExpand
  • 12
  • PDF
Not traditional prognostic factors in human conventional renal carcinoma.
The evaluation of know prognostic factors is an essential step of the assessment of the patients affected by primary renal carcinoma. As long as the major biological mechanisms of renal carcinomasExpand
  • 4
PO-038 PDGFRβ as a new biomarker for metastatic triple-negative breast cancer: development of a theranostic anti-PDGFRβ aptamer for imaging and suppression of metastases
Introduction Triple-negative breast cancers (TNBCs) are a heterogeneous group of aggressive tumours lacking oestrogen and progesterone receptors and HER2 receptor, thus excluding the possibility ofExpand
Modification of Al/GaAs(001) Schottky barriers by means of heterovalent interface layers
The Schottky barrier height in Al/Si/GaAs(001) junctions grown by molecular‐beam epitaxy was determined in situ by means of x‐ray photoemission spectroscopy and ex situ through current–voltage andExpand
  • 17
Circulating tumour cells (CTCs) have recently evoked much interest in cancer research, representing potential prognostic biomarkers and a reliable mean to predict metastasis development. The presenceExpand